Journal Club: Pathogen-Reduced Red Blood Cells in Cardiac Surgery: The ReCePI Trial

Presented by

Dr. Naif Muhannaa

MD, Physician Trainee 

Canadian Blood Services

Learning objectives

1. Describe the rationale for pathogen-reduced red blood cells.
2. Explain the clinical question and design of the ReCePI trial.
3. Interpret the main efficacy and safety findings of the trial.
4. Critically appraise the strengths and limitations of the study.
5. Discuss how ReCePI may inform future transfusion medicine practice.

Additional Resources: 

Transfusion of Amustaline/Glutathione Pathogen-reduced Red Blood Cells in Cardiac Surgery: A Randomized Phase 3 Clinical Trial

Registration

TBA

Appraisal

TBA

To be added to the distribution list for the LearnTransfusion series, send an email to learn.transfusion@blood.ca  with “Weekly Transfusion Medicine Seminars” in the subject line. Include your name and complete e-mail address in the body of the e-mail and confirm that you would like to be added to the distribution list for the LearnTransfusion series. You will then receive weekly email notifications of upcoming series events with details on how to join the webinars (e.g.,  link to register for the webinar).

The LearnTransfusion series is the seminar component of the Areas of Focused Competency (AFC)-Diploma Program in Transfusion Medicine. The series, organized by Canadian Blood Services, is also open to all practitioners in the field of Transfusion Medicine. Through a series of regular webinars, trainees and practitioners are exposed to various scientific, technical and clinical aspects of transfusion medicine.